期刊文献+

右美托咪啶辅助颈丛神经阻滞用于锁骨骨折内固定术的临床观察 被引量:8

下载PDF
导出
摘要 右美托咪啶是一种新型高效和高选择性的仅,肾上腺能受体激动药,具有剂量依赖性镇静催眠作用和镇痛、抑制交感活性等药理性质,无呼吸抑制作用。近年来国内外围术期的应用证实右美托咪啶可使麻醉药用量明显减少,并能稳定血流动力学。本科在锁骨骨折内固定术中采用右美托咪啶辅助颈丛神经阻滞,麻醉效果满意。现将一组病例资料报告如下。
出处 《浙江临床医学》 2013年第2期260-261,共2页 Zhejiang Clinical Medical Journal
  • 相关文献

参考文献8

  • 1Carollo DS, Nossaman BD, Ramadhyani U.Dexmedetomodine:a review of clinical applications.Curt Opin Anesthesiol, 2008, 21(4):457-461.
  • 2Bekper A, Sturaitis M, Bloom M, et al.The effectofdexmedetomidine on perioperative hemodynamics in patient undergoing eraniotomy. Anesth Analg, 2008, 107(4):1340.
  • 3Pentii J, Helminen A,. Anttila M. et al. Caradiovaseular and parasympathetic effects o- dexrnetomidine in healthy subjects. Canadian J Physiology and pharmacology, 2004, 82:359.
  • 4Hunter JC, Fontana DJ, Hedley LR.et al.Assessment of the role of alpha 2 adrenoceptor subtypes in the antinociceptive sedative and hypethemic in transgenic mice.BrJ Phamacol, 1997, 122:1339-1344.
  • 5Eisenach JC.Alpha agonists and analgesia , Exp Opin Invest Drug, 1994, 3:1005-1010.
  • 6Ebert TJ, Hall JE, Bamey JA. et al.The effects of increasing plasm a concentrations of dexmedetomidine in humans.Anesthesiology, 2000, 93:382-394.
  • 7Ikamsey MA, Luterman DL.Dexmedetomidine as a total intravenous anesthetic agent.Anesthesiology, 2004, 10l :781-787.
  • 8李民,张利萍,吴新民.右美托咪啶在临床麻醉中应用的研究进展[J].中国临床药理学杂志,2007,23(6):466-470. 被引量:483

二级参考文献39

  • 1[1]Khan ZP,Ferguson CN,Jones RM.Alpha-2 and imidazoline receptor agonists:their pharmacology and therapeutic role[J].Anesthesia,1999;54:146-165.
  • 2[2]Kamibayashi T,Maze M.Clinical uses of alpha 2-adrenergic agonists[J].Anesthesiology,2000;93:1345-1350.
  • 3[3]Calzada BC,De Artinano AA.[alpha]2-Adrenoreceptor subtypes[J].Pharmacol Res,2001;44:195-208.
  • 4[4]Hunter JC,Fontanna DJ,Hedley LR,et al.Assessment of the role of alpha 2-adrenoceptor subtypes in the antinociceptive,sedative and hypothermic action of dexmedetomidine in transgenic mice[J].Br J Pharmacol,1997;122:1339-1344.
  • 5[5]Nelson LE,Lu J,Guo TZ,et al.The α2-Adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects[J].Anesthesiology,2003;98:428-436.
  • 6[6]Coull JT,Jones M,Egan T,et al.Attentionla effects of noradranaline vary with arousal level:selective activation of thalamie pulvinar in humans[J].Neuro Image,2004;22:315-322.
  • 7[7]Eisenach JC.[Alpha]2 agonists and analgesia[J].Exp Opin Invest Drugs,1994;3:1005-1010.
  • 8[8]Ma D,Rajakumamswamy N,Maze M.Alpha2-Adrenoceptor agonists:shedding light on neuroprotection?[J].Br Med Bull,2005;71:77-92.
  • 9[9]Ebert TJ,Hall JE,Barney JA,et al.The effects of increasing plasma concentrations of dexmedetomidine in humans[J].Anesthesiology,2000;93:382-394.
  • 10[10]Ramsey MA,Luterman DL.Dexmedetomidine as a total intravenous anesthestic agent[J].Anesthesiology,2004;101:787-781.

共引文献482

同被引文献59

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部